Animal Health Production Facility
Dedicated to advancing veterinary medicine, the future Animal Health Production Facility will produce safe and effective treatments for both livestock and companion animals, supporting health across the agricultural sector.
Biotech (Synthesis) Production Facility
This upcoming Biotech Synthesis facility will focus on producing complex biopharmaceutical compounds. Utilizing cutting-edge synthesis and recombinant DNA technologies, it will drive forward our capabilities in innovative treatments.
Antibody Production Facility
Planned to support biomedical research, this facility will specialize in producing high-purity, research-grade antibodies. With a focus on diagnostics and therapeutic research, it will bolster advancements in life sciences.
Penicillin Production Facility
This upcoming Penicillin Production Unit is being developed to expand antibiotic production with advanced fermentation and purification processes ensuring access to high-quality penicillin-based treatments for global health needs.
Large Volume Parenteral Facility
Planned to meet critical patient care needs, this future facility will manufacture sterile intravenous solutions. Equipped with advanced aseptic filling and packaging systems, it aims to ensure the highest quality and safety standards.
